LOGIN

International Epidemiology Databases to Evaluate AIDS

Home >> Publications >> Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

Publication

Author(s):

Jansson J, Wilson DP, Carr A, Petoumenos K, Boyd MA.

Pub Title:

Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

Pub Date:

May 15 2013

Pub Region(s):

Asia-Pacific

Journal Issue:

Epub

Page Number:
Epub

Journal:

Title: 
AIDS
Link: 
http://ovidsp.tx.ovid.com/sp-3.10.0b/ovidweb.cgi?QS2=434f4e1a73d37e8c6056533a8d0c69ecf501dc93910f382c46e51ebf752e7c081e4e2ee17771729d53c0bcf5f343a76e0ed0e6648d0992f546d5d5dd8f8ddd086b704d9c11c17c6a5a248db224a51fca5eaca0e6129d4186017596a6d19ce3013122a13e6f

PubMed: 23276809

Abstract
OBJECTIVE
: Combination antiretroviral therapy (cART) has greatly improved the life expectancy of people living with HIV (PLHIV). Our study aims to project the life expectancy of PLHIV in a resource-rich setting in the context of the currently available antiretroviral treatments.

METHODS: Patient antiretroviral treatment data were sourced from an observational cohort of 3434 predominantly male (94.2%) PLHIV in Australia over the period 1997-2010. These data were analyzed in a computer simulation model to calculate the distribution of time until exhaustion of all treatment options and expected effect on mortality. Standardized mortality ratios were used to simulate expected survival before and after treatment exhaustion.

RESULTS: We estimated that the median time until exhaustion of currently available treatment options is 45.5 years [interquartile range (IQR) 34.0-61.0 years]. However, 10% of PLHIV are expected to exhaust all currently available cART options after just 25.6 years. PLHIV who start currently available cART regimens at age 20 years are expected to live to a median age of 67.4 (IQR 53.2-77.7) years. This is a substantial improvement on no cART [27.7 (IQR 23.8-32.0) years] but is still substantially less than the median general population mortality age [82.2 (IQR 74.0-87.8) years]. The life expectancy gap between PLHIV and the general population is greatest for those infected at younger ages.

CONCLUSION: As treatment options are exhausted, a substantial difference in life expectancy between PLHIV and the general population could be expected even in resource-rich settings, particularly for people who acquire HIV at a younger age or who are currently highly treatment experienced.

PMID: 23276809 [PubMed - in process]

PMCID: PMC3740079

 

The following websites provide guidelines and policies when citing from PubMed®: http://www.ncbi.nlm.nih.gov/books/NBK7243/
http://www.nlm.nih.gov/bsd/policy/cit_format.html

Citation:

Jansson J, Wilson DP, Carr A, Petoumenos K, Boyd MA. Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV. AIDS. 2013 May 15;27(8):1245-51. doi: 10.1097/QAD.0b013e32835e163d. PubMed PMID: 23276809; PubMed Central PMCID: PMC3740079.